Contact your GP if fatigue persists beyond several months, worsens progressively, significantly impairs daily activities, or is accompanied by severe gastrointestinal symptoms, signs of dehydration, or symptoms of hypoglycaemia
With roughly 42% of American adults identifying as obese, it's time to unveil the ultimate weapons against this heavyweight foe
Following the expiry of semaglutides patent in India (March 2021, 2026), the market changed dramatically.[13][14] 40+ Indian pharma companies launched generic GLP-1 medications[12] Prices dropped by ~80% Key players include: Sun Pharma Dr
In SUSTAIN-7, a study comparing semaglutide to dulaglutide in patients with inadequately controlled T2DM, a greater reduction in body weight was observed with 0.5 mg semaglutide (4.6 kg, standard error [SE] 0.28) compared with 0.75 mg dulaglutide (2.3 kg, SE 0.27) (estimated treatment difference [ETD] 2.26 kg, 95% CI 3.02 to 1.51
While there are case reports that claim GLP-1RA therapy caused or led to progression of pancreatic cystic disease, the claims for causality are not well supported 54,55